B. Riley Starts Tandem Diabetes (TNDM) at Buy
Tweet
Share
E-mailGet Alerts TNDM Hot Sheet
Price: $23.73 --0%
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Join SI Premium – FREE
B. Riley initiated coverage on Tandem Diabetes (NASDAQ: TNDM) with a Buy rating and a price target of $10.00.
For an analyst ratings summary and ratings history on Tandem Diabetes click here. For more ratings news on Tandem Diabetes click here.
Shares of Tandem Diabetes closed at $8.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Starts Aktis Oncology (AKTS) at Outperform
- BMO Capital Starts BioMarin Pharmaceutical Inc. (BMRN) at Outperform
- BMO Capital Starts Exelixis (EXEL) at Market Perform
Create E-mail Alert Related Categories
New CoverageRelated Entities
B. RileySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
